You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
AstraZeneca
Medtronic
Express Scripts
Moodys

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories LLC v. Apotex Corp. (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Forest Laboratories LLC v. Apotex Corp.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Forest Laboratories LLC v. Apotex Corp. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-08-19 109 INTRODUCTION The two patents in suit—U.S. Patent Nos. 6,417,175 (“the ’175 patent”) and 8,247,400 (“the….S. Patent Nos. 6,906,055 (“the ’055 patent”), 7,419,973 (“the ’973 patent”), and the ’175 patent as …as well as the ’400 patent. (D.I. 1.) But the ‘055 patent and the ‘973 patent are no longer in the case…” evidence—the patent’s claims, specification and file history. To be valid, a patent claim must allow…regarding the ’175 patent (D.I. 103), Sandoz takes no position on the disputed ’175 patent claim terms. External link to document
2016-11-07 140 the asserted claims ofU.S. Patent Nos. 6,417,175 ("the '175 patent") and 8,247,400 ("… ORDER CONSTRUING THE TERMS of U.S. Patent Nos. 6,417,175 and 8,247,400. Signed by Judge Gregory M…TERMS OF U.S. PATENT NOS. 6,417,175 AND 8,247,400 After having considered…carboxylic acid, it does so explicitly. U.S. Patent No. 6,417,175 col. 2111. 51-60 (filed June 6, 2000). It…quot;the '400 patent"): A. The '175 patent . 1. The term External link to document
2015-01-04 5 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,417,175 B1; 6,906,055 B2; 7,419,973…2015 17 January 2017 1:15-cv-00018 830 Patent Defendant District Court, D. Delaware External link to document
2016-04-25 79 and specification of U.S. Patent No. 6,417,175 ("the '175 patent"), including Claims 5-… and specification of U.S. Patent No. 6,417,175 ("the '175 patent"), including Claim 14 … and specification of U.S. Patent No. 6,417,175 ("the '175 patent"), including Claims 1 … and specification of U.S. Patent No. 6,417,175 ("the '175 patent"), including Claims 1 …Final Joint Claim Chart with regard to U.S. Patents Nos. 6,417,175, 6,906,055 and 7,419,973.1 1 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
Baxter
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.